NCT00005061View on ClinicalTrials.gov

Monoclonal Antibody Therapy in Treating Patients With Relapsed or Refractory Solid Tumors

PHASE1CompletedINTERVENTIONAL
Enrollment

20

Participants

Timeline

Start Date

December 31, 1999

Primary Completion Date

June 30, 2001

Conditions
Unspecified Adult Solid Tumor, Protocol Specific
Interventions
BIOLOGICAL

bevacizumab

Trial Locations (4)

6202 AZ

Academisch Ziekenhuis Maastricht, Maastricht

3508 GA

Academisch Ziekenhuis Utrecht, Utrecht

S-581 85

University Hospital of Linkoping, Linköping

M20 4BX

Christie Hospital N.H.S. Trust, Manchester

All Listed Sponsors
lead

European Organisation for Research and Treatment of Cancer - EORTC

NETWORK

NCT00005061 - Monoclonal Antibody Therapy in Treating Patients With Relapsed or Refractory Solid Tumors | Biotech Hunter | Biotech Hunter